A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that causes vomiting and diarrhoea. The easily spreadable winter virus can affect people of all ages and have huge consequences - often closing hospital wards, taking children out of school and keeping parents off work.

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

A groundbreaking vaccine for norovirus, the notorious winter vomiting bug, is set to enter final-stage trials in the UK within the next fortnight. Developed by Moderna using mRNA technology, the jab aims to combat three major strains of the highly contagious virus.

A vaccine for the vomiting bug norovirus is being trialled in the UK for the first time, with the hope it could cut the “burden on the NHS”, the Health Secretary has said. The new mRNA vaccine from Moderna will enter final stages of testing within the next two weeks,

A vaccine to guard against the winter vomiting bug norovirus is set for a year-long groundbreaking NHS trial after early results showed it creates a “strong immune response”. It is hoped an effective norovirus vaccine,

A trial in the UK will see a norovirus given to patients with the Health Secretary hoping it will cut the “burden on the NHS”.

A first-of-its-kind vaccine against the vomit bug norovirus is being trialled in the UK, using the same tech employed in the Covid jab. Thousands of Brits end up in hospital every year due to the highly contagious virus,